Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 6—June 2021
Online Report

Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level

Vahid Salimi, Mariana Viegas1, Alfonsina Trento1, Charles N. Agoti, Larry J. Anderson, Vasanthi Avadhanula, Justin Bahl, Louis Bont, J. Rodney Brister, Patricia A. Cane, Mónica Galiano, Barney S. Graham, Eneida L. Hatcher, Orienka Hellferscee, David M. Henke, Siddhivinayak Hirve, Sandra Jackson, Els Keyaerts, Leyla Kragten-Tabatabaie, Stephen Lindstrom, Inne Nauwelaers, D. James Nokes, Peter J. Openshaw, Teresa C. Peret, Pedro A. Piedra, Kaat Ramaekers, Annabel Rector, Nídia Sequeira Trovão, Anne von Gottberg, Maria Zambon, Wenqing Zhang, Thomas C. Williams, Ian G. Barr2Comments to Author , and Ursula J. Buchholz2Comments to Author 
Author affiliations: Tehran University of Medical Sciences, Tehran, Iran (V. Salimi); Hospital de Niños Dr. Ricardo Gutiérrez, Buenos Aires, Argentina (M. Viegas); National Center of Biotechnology, Madrid, Spain (A. Trento); KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya (C.N. Agoti, D.J. Nokes); Emory University, Atlanta, Georgia, USA (L.J. Anderson); Baylor College of Medicine, Houston, Texas, USA (V. Avadhanula, D.M. Henke, P.A. Piedra); University of Georgia, Athens, Georgia, USA (J. Bahl); University Medical Center, Utrecht, the Netherlands (L. Bont); National Center for Biotechnology Information, Bethesda, Maryland, USA (J.R. Brister, E.L. Hatcher); Public Health England, London, UK (P.A. Cane, M. Galiano, I. Nauwelaers, M. Zambon); Francis Crick Institute, London (M. Galiano); National Institute of Allergy and Infectious Diseases, Bethesda (B.S. Graham, U.J. Buchholz); National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa (O. Hellferscee, A. von Gottberg); W; orld Health Organization, Geneva, Switzerland (S. Hirve, S. Jackson, W. Zhang); University Hospitals Leuven, Leuven, Belgium (E. Keyaerts); ReSViNET Foundation, Zeist, the Netherlands (L. Kragten-Tabatabaie); Julius Clinical, Zeist (L. Kragten-Tabatabaie); Centers for Disease Control and Prevention, Atlanta (S. Lindstrom, T. Peret); Imperial College London, London (I. Nauwelaers, P. Openshaw); Rega Institute, Leuven (K. Ramaekers, A. Rector); Fogarty International Center, Bethesda (N. Sequeira Trovão); University of Edinburgh, Edinburgh, Scotland, UK (T.C. Williams); Peter Doherty Institute for Infection & Immunity, Melbourne, Victoria, Australia (I. Barr)

Main Article

Figure 4

Schematic aid to gene annotations of HRSV whole-genome sequences. An HRSV gene comprises the sequence from the first nucleotide of the conserved HRSV gene start signal (GGGGCAAATa) to the last adenosine residue of the HRSV gene end signal (AGTTAnnnnAAAA) (25,41). Gene start signals are represented by black triangles, and gene end signals are shown as black rectangles, separated by intergenic regions (underlined). Note the M2/L gene overlap (annotations derived from HRSV A2; GenBank accession no. M74568/NC_038235). le, leader region; HRSV, human respiratory syncytial virus; tr, trailer region.

Figure 4. Schematic aid to gene annotations of HRSV whole-genome sequences. An HRSV gene comprises the sequence from the first nucleotide of the conserved HRSV gene start signal (GGGGCAAATa) to the last adenosine residue of the HRSV gene end signal (AGTTAnnnnAAAA) (25,41). Gene start signals are represented by black triangles, and gene end signals are shown as black rectangles, separated by intergenic regions (underlined). Note the M2/L gene overlap (annotations derived from HRSV A2; GenBank accession no. M74568/NC_038235). le, leader region; HRSV, human respiratory syncytial virus; tr, trailer region.

Main Article

References
  1. Shi  T, McAllister  DA, O’Brien  KL, Simoes  EAF, Madhi  SA, Gessner  BD, et al.; RSV Global Epidemiology Network. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390:946–58. DOIPubMedGoogle Scholar
  2. Nair  H, Nokes  DJ, Gessner  BD, Dherani  M, Madhi  SA, Singleton  RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375:1545–55. DOIPubMedGoogle Scholar
  3. Salimi  V, Tavakoli-Yaraki  M, Yavarian  J, Bont  L, Mokhtari-Azad  T. Prevalence of human respiratory syncytial virus circulating in Iran. J Infect Public Health. 2016;9:125–35. DOIPubMedGoogle Scholar
  4. Stein  RT, Bont  LJ, Zar  H, Polack  FP, Park  C, Claxton  A, et al. Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis. Pediatr Pulmonol. 2017;52:556–69. DOIPubMedGoogle Scholar
  5. O’Brien  KL, Baggett  HC, Brooks  WA, Feikin  DR, Hammitt  LL, Higdon  MM, et al.; Pneumonia Etiology Research for Child Health (PERCH) Study Group. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study. Lancet. 2019;394:757–79. DOIPubMedGoogle Scholar
  6. Falsey  AR, Hennessey  PA, Formica  MA, Cox  C, Walsh  EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352:1749–59. DOIPubMedGoogle Scholar
  7. Rima  B, Collins  P, Easton  A, Fouchier  R, Kurath  G, Lamb  RA, et al.; Ictv Report Consortium. ICTV virus taxonomy profile: Pneumoviridae. J Gen Virol. 2017;98:2912–3. DOIPubMedGoogle Scholar
  8. Agoti  CN, Phan  MVT, Munywoki  PK, Githinji  G, Medley  GF, Cane  PA, et al. Genomic analysis of respiratory syncytial virus infections in households and utility in inferring who infects the infant. Sci Rep. 2019;9:10076. DOIPubMedGoogle Scholar
  9. Trovao  NS, Khuri-Bulos  N, Tan  Y, Puri  V, Shilts  MH, Halpin  RA, et al. Molecular characterization of respiratory syncytial viruses circulating in a paediatric cohort in Amman, Jordan. Microb Genom. 2019 Sep 18 [Epub ahead of print].
  10. Geis  S, Prifert  C, Weissbrich  B, Lehners  N, Egerer  G, Eisenbach  C, et al. Molecular characterization of a respiratory syncytial virus outbreak in a hematology unit in Heidelberg, Germany. J Clin Microbiol. 2013;51:155–62. DOIPubMedGoogle Scholar
  11. Nabeya  D, Kinjo  T, Parrott  GL, Uehara  A, Motooka  D, Nakamura  S, et al. The clinical and phylogenetic investigation for a nosocomial outbreak of respiratory syncytial virus infection in an adult hemato-oncology unit. J Med Virol. 2017;89:1364–72. DOIPubMedGoogle Scholar
  12. Hall  CB, Walsh  EE, Schnabel  KC, Long  CE, McConnochie  KM, Hildreth  SW, et al. Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis. 1990;162:1283–90. DOIPubMedGoogle Scholar
  13. Malekshahi  SS, Razaghipour  S, Samieipoor  Y, Hashemi  FB, Manesh  AAR, Izadi  A, et al. Molecular characterization of the glycoprotein and fusion protein in human respiratory syncytial virus subgroup A: Emergence of ON-1 genotype in Iran. Infect Genet Evol. 2019;71:166–78. DOIPubMedGoogle Scholar
  14. Vos  LM, Oosterheert  JJ, Kuil  SD, Viveen  M, Bont  LJ, Hoepelman  AIM, et al. High epidemic burden of RSV disease coinciding with genetic alterations causing amino acid substitutions in the RSV G-protein during the 2016/2017 season in The Netherlands. J Clin Virol. 2019;112:20–6. DOIPubMedGoogle Scholar
  15. Pierangeli  A, Viscido  A, Bitossi  C, Frasca  F, Gentile  M, Oliveto  G, et al. Differential interferon gene expression in bronchiolitis caused by respiratory syncytial virus-A genotype ON1. Med Microbiol Immunol (Berl). 2020;209:23–8. DOIPubMedGoogle Scholar
  16. Vandini  S, Biagi  C, Lanari  M. Respiratory syncytial virus: the influence of serotype and genotype variability on clinical course of infection. Int J Mol Sci. 2017;18:1717. DOIPubMedGoogle Scholar
  17. Laham  FR, Mansbach  JM, Piedra  PA, Hasegawa  K, Sullivan  AF, Espinola  JA, et al. Clinical profiles of respiratory syncytial virus subtypes A and B among children hospitalized with bronchiolitis. Pediatr Infect Dis J. 2017;36:808–10. DOIPubMedGoogle Scholar
  18. Gilca  R, De Serres  G, Tremblay  M, Vachon  ML, Leblanc  E, Bergeron  MG, et al. Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons. J Infect Dis. 2006;193:54–8. DOIPubMedGoogle Scholar
  19. Martinello  RA, Chen  MD, Weibel  C, Kahn  JS. Correlation between respiratory syncytial virus genotype and severity of illness. J Infect Dis. 2002;186:839–42. DOIPubMedGoogle Scholar
  20. Measles virus nomenclature update: 2012. Wkly Epidemiol Rec. 2012;87:73–81.PubMedGoogle Scholar
  21. Kuhn  JH, Bao  Y, Bavari  S, Becker  S, Bradfute  S, Brister  JR, et al. Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae. Arch Virol. 2013;158:1425–32. DOIPubMedGoogle Scholar
  22. Matthijnssens  J, Ciarlet  M, McDonald  SM, Attoui  H, Bányai  K, Brister  JR, et al. Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol. 2011;156:1397–413. DOIPubMedGoogle Scholar
  23. Reconsideration of influenza A virus nomenclature: a WHO memorandum. Bull World Health Organ. 1979;57:227–33.PubMedGoogle Scholar
  24. Collins  PL, Fearns  R, Graham  BS. Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease. Curr Top Microbiol Immunol. 2013;372:3–38. DOIPubMedGoogle Scholar
  25. Collins  PL, Karron  RA. Respiratory syncytial virus and metapneumovirus. In: Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, et al., editors. Fields Virology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 1086–123.
  26. Collins  PL, Melero  JA. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res. 2011;162:80–99. DOIPubMedGoogle Scholar
  27. Mufson  MA, Orvell  C, Rafnar  B, Norrby  E. Two distinct subtypes of human respiratory syncytial virus. J Gen Virol. 1985;66:2111–24. DOIPubMedGoogle Scholar
  28. Collins  PL, Olmsted  RA, Spriggs  MK, Johnson  PR, Buckler-White  AJ. Gene overlap and site-specific attenuation of transcription of the viral polymerase L gene of human respiratory syncytial virus. Proc Natl Acad Sci U S A. 1987;84:5134–8. DOIPubMedGoogle Scholar
  29. Mink  MA, Stec  DS, Collins  PL. Nucleotide sequences of the 3′ leader and 5′ trailer regions of human respiratory syncytial virus genomic RNA. Virology. 1991;185:615–24. DOIPubMedGoogle Scholar
  30. O’Leary  NA, Wright  MW, Brister  JR, Ciufo  S, Haddad  D, McVeigh  R, et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res. 2016;44(D1):D733–45. DOIPubMedGoogle Scholar
  31. Sayers  EW, Beck  J, Brister  JR, Bolton  EE, Canese  K, Comeau  DC, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2020;48(D1):D9–16. DOIPubMedGoogle Scholar
  32. Karron  RA, Buonagurio  DA, Georgiu  AF, Whitehead  SS, Adamus  JE, Clements-Mann  ML, et al. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc Natl Acad Sci U S A. 1997;94:13961–6. DOIPubMedGoogle Scholar
  33. Martínez  I, Dopazo  J, Melero  JA. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. J Gen Virol. 1997;78:2419–29. DOIPubMedGoogle Scholar
  34. Trento  A, Ábrego  L, Rodriguez-Fernandez  R, González-Sánchez  MI, González-Martínez  F, Delfraro  A, et al. Conservation of G-protein epitopes in respiratory syncytial virus (group A) despite broad genetic diversity: is antibody selection involved in virus evolution? J Virol. 2015;89:7776–85. DOIPubMedGoogle Scholar
  35. Melero  JA, García-Barreno  B, Martínez  I, Pringle  CR, Cane  PA. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein. J Gen Virol. 1997;78:2411–8. DOIPubMedGoogle Scholar
  36. Sullender  WM, Mufson  MA, Anderson  LJ, Wertz  GW. Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses. J Virol. 1991;65:5425–34. DOIPubMedGoogle Scholar
  37. Cane  PA, Matthews  DA, Pringle  CR. Analysis of respiratory syncytial virus strain variation in successive epidemics in one city. J Clin Microbiol. 1994;32:1–4. DOIPubMedGoogle Scholar
  38. Goya  S, Galiano  M, Nauwelaers  I, Trento  A, Openshaw  PJ, Mistchenko  AS, et al. Toward unified molecular surveillance of RSV: A proposal for genotype definition. Influenza Other Respir Viruses. 2020;14:274–85. DOIPubMedGoogle Scholar
  39. Ramaekers  K, Rector  A, Cuypers  L, Lemey  P, Keyaerts  E, Van Ranst  M. Towards a unified classification for human respiratory syncytial virus genotypes. Virus Evol. 2020;6:veaa052.
  40. The GenBank Submissions Handbook. Bethesda (MD): National Center for Biotechnology Information; 2011.
  41. Collins  PL, Dickens  LE, Buckler-White  A, Olmsted  RA, Spriggs  MK, Camargo  E, et al. Nucleotide sequences for the gene junctions of human respiratory syncytial virus reveal distinctive features of intergenic structure and gene order. Proc Natl Acad Sci U S A. 1986;83:4594–8. DOIPubMedGoogle Scholar
  42. Trento  A, Casas  I, Calderón  A, Garcia-Garcia  ML, Calvo  C, Perez-Breña  P, et al. Ten years of global evolution of the human respiratory syncytial virus BA genotype with a 60-nucleotide duplication in the G protein gene. J Virol. 2010;84:7500–12. DOIPubMedGoogle Scholar
  43. Graham  BS. Vaccine development for respiratory syncytial virus. Curr Opin Virol. 2017;23:107–12. DOIPubMedGoogle Scholar
  44. Mazur  NI, Higgins  D, Nunes  MC, Melero  JA, Langedijk  AC, Horsley  N, et al.; Respiratory Syncytial Virus Network (ReSViNET) Foundation. The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. Lancet Infect Dis. 2018;18:e295–311. DOIPubMedGoogle Scholar
  45. Collins  PL, Hill  MG, Camargo  E, Grosfeld  H, Chanock  RM, Murphy  BR. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc Natl Acad Sci U S A. 1995;92:11563–7. DOIPubMedGoogle Scholar
  46. Crowe  JE Jr, Bui  PT, Firestone  CY, Connors  M, Elkins  WR, Chanock  RM, et al. Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates. J Infect Dis. 1996;173:829–39. DOIPubMedGoogle Scholar

Main Article

1These authors contributed equally to this article.

2These last authors contributed equally to this article.

Page created: April 21, 2021
Page updated: May 18, 2021
Page reviewed: May 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external